You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 57.3 KDa. Observed: 80-95 KDa, reducing conditions
Human
Pro20-Lys291
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.31 KDa. Observed: 18-25 KDa, reducing conditions
Human
Gly30-Gly154
C-6His
10 μg, 500 μg, 1 mg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 50.8 KDa. Observed: 50-65 KDa, reducing conditions
Human
Gln30-Gly254
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.79 KDa. Observed: 30 KDa, reducing conditions
Human
Lys31-Leu150
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 22.29 KDa. Observed: 26 KDa, reducing conditions
Human
Met1-Asn188
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.34 KDa. Observed: 25-35 KDa, reducing conditions
Human
Gln21-Ser189
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 41.34 KDa. Observed: 58-85 KDa, reducing conditions
Human
Gly40-His393
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.04 KDa. Observed: 16 KDa, reducing conditions
Human
Ile22-Leu166
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 25.58 KDa. Observed: 30 KDa, reducing conditions
Human
Glu19-Asn244
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 11.07 KDa. Observed: 18-22 KDa, reducing conditions
Human
Glu31-Phe124
C-6His
10 μg, 50 μg, 500 μg, 1 mg
